7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
1/17
PREVIOUS NEXT
PREVIOUS NEXT
Using Oracle's Empirica Topics to Document Your
Signal Management Process
July 26, 2013
Rodney Lemery, MPH, PhD
Vice President, Safety andPharmacovigilance
BioPharm Systems, Inc.
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
2/17
PREVIOUS NEXT
Agenda
Signal Management using Oracle Empirica
Products Detection
Use of e-Signal for data mining
Prioritization
Evaluation
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
3/17
PREVIOUS NEXT
Signal Management
The process of identifying, prioritizing and evaluating
determined signals in a data population
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
4/17
PREVIOUS NEXT
Current Regulatory EnvironmentAs of July 2, 2012, the EMA has required among other things All validation, prioritisation, assessment, timelines, decisions, actions, plans,
reporting as well as all other key steps should be recorded and trackedsystematically. Tracking systems should be used for documentation and should
also include signals, for which the validation process conducted was notsuggestive of a new potentially causal association, or a new aspect of a knownassociation. All records need to be archived (EMA, 2012).
In June of 2002, the US Congress reauthorized (for a secondtime) the Prescription Drug User Fee Act (PDUFA III)
Specifically, FDA issued three concept papers. Each paper focused onone aspect of risk management, includingo (1) conducting premarketing risk assessment
o (2) developing and implementing risk minimization tools
o (3) performing post marketing pharmacovigilance and pharmacoepidemiologicassessments. (FDA, 2005)
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
5/17
PREVIOUS NEXT
What the Industry Seeks
A systematic approach to signalmanagement
Ability to identify potential issues in clinical and post-marketing data
Standard prioritization questions
Standard evaluation methods to feed risk management
Pre-defined workflow for these processes
A system to collect and track thisapproach Standard system to document the identification,
prioritization and evaluation of signals
Capability to report this process for audit answeringand justification or risk methods (document duediligence)
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
6/17
PREVIOUS NEXT
Empirica Topics Workflow Example
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
7/17PREVIOUS NEXT
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
8/17PREVIOUS NEXT
Actions can be created and assigned to other users in the company
In this example, an action to review the case series is assigned
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
9/17PREVIOUS NEXT
Signals prioritized as
High or Medium are
moved into the Signal
Evaluation workflowstep for further
investigation and
signal workup
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
10/17PREVIOUS NEXT
Additional
external
documentationcan also be
attached to the
topic to
support the
prioritization of
the signal
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
11/17PREVIOUS NEXT
Using e-Signal, we can drill
down into the case series
that makes up the signal of
interest
The case series can
be attached to the
topic of interest for
historical
identification
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
12/17PREVIOUS NEXT
Additional
external
documentati
on can alsobe attached
to the topic
to support
the
evaluationof the signal
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
13/17PREVIOUS NEXT
Using the default abilities of e-Topics, we can run reports documenting
our signal management process at the request of a regulatory
authority or equivalent
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
14/17PREVIOUS NEXT
Complete auditing of the topic case
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
15/17PREVIOUS NEXT
Summary
Using existing literature and Empirica Suite can be configured to
provide a systematic method for signal management in a single
solution that accomplishes the following:
Ability to identify potential issues in clinical and post-marketingdata
Standard prioritization questions
Standard evaluation methods to feed risk management
Pre-defined workflow for these processes
Capability to report this process for audit answering and
justification or risk methods (document due diligence)
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
16/17PREVIOUS NEXT
References Bennett Levitan, B., Yee, C. L., Russo,L., Bayney, R., Thomas, A. P. and Klincewicz, S.
L.. (2008). A Model for Decision Support in Signal Triage. Drug Safety. 31 (9), pp.727-735
Council for International Organizations of Medical Sciences (CIOMS). (2010).
Practical Aspects of Signal Detection in Pharmacovigilance. Report of CIOMSWorking Group VIII, Geneva .
Heeley E, Waller P, and Moseley J. (2005). Testing and implementing signal impactanalysis in a regulatory setting: results of a pilot study. Drug Safety28 (10), pp.901-6
Waller P, Heeley E, and Moseley J. (2005). Impact analysis of signals detectedfrom spontaneous adverse drug reaction reporting. Drug Safety28 (1), pp. 843-50
Waller P, Lee E. (1999). Responding to drug safety issues. Pharmacoepidemiologyand Drug Safety8 (7), pp. 535-52
Waller, P. (2010). An Introduction to Pharmacovigilance. Wiley-Blackwell. Oxford,UK
7/27/2019 2013 OHSUG - Using Oracle's Empirica Topics to Document Your Signal Management Process
17/17PREVIOUS NEXT
Questions & Answers
2000 Alameda de las PulgasSuite 154
San Mateo, CA 94403-1270
www.biopharm.com
Rodney L. Lemery MPH, PhDVice Pres. Safety and PV
Tel (650) 292-5310
Fax (650) 292-5301
http://www.biopharm.com/mailto:[email protected]:[email protected]://www.biopharm.com/